Home › Germ Cell and Embryonal Cancer › Massachusetts
Germ Cell and Embryonal Cancer clinical trials in Massachusetts
3 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Dana-Farber/Harvard Cancer Center, Boston
RecruitingPhase 3
Ages 11 to 50 · All sexes · Updated Sep 1, 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Tufts Medical Center, Boston
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
- and 2 more
RecruitingPhase 3
All ages · All sexes · Updated Aug 25, 2026 · NCT03067181A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Massachusetts General Hospital,, Boston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.